Product Information
DORZOLAMIDE-TIMOLOL 2-0.5%(PF) is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1320 per EA under NDC 65862094760. Its NADAC has been published 396 times since Jan 23, 2019.
FDA first approved this application on Jul 24, 2018. Its Orange Book therapeutic-equivalence code is AT2.
DORZOLAMIDE-TIMOLOL 2-0.5%(PF)
Dorzolamide Hydrochloride and Timolol Maleate Preservative FreeStrength
20; 5 mg/mL; mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862094760
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA207630FDA Approved
7/24/2018
TE Code
AT2
On Market Since
7/24/2018
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has been published 396 times since Jan 23, 2019, and over the history we have for it it has declined 49.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1320 per EA |
|---|---|
| All-time high | $2.2200 (Feb 13, 2019) |
| All-time low | $0.9746 (Nov 20, 2024) |
| 52-week high | $1.1462 |
| 52-week low | $1.0471 |
| Median price | $1.7427 |
| Average price | $1.6279 |
| Largest weekly change | +40.7% (Jun 19, 2024) |
| Weeks tracked | 396 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dorzolamide Hydrochloride and Timolol Maleate Preservative Free market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL 2-0.5%(PF), manufactured by Aurobindo Pharma Limited, is $1.1320 per EA (NDC 65862094760), effective Aug 19, 2026.
How has the price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has declined 49.0%. It has been tracked across 396 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
Since Jan 23, 2019, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has ranged from a low of $0.9746 (Nov 20, 2024) to a high of $2.2200 (Feb 13, 2019), with a median of $1.7427 per EA.
Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
DORZOLAMIDE-TIMOLOL 2-0.5%(PF) (NDC 65862094760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.